SCHEMBL6987065

SCHEMBL6987065

CCN(CCCCN1CCCCCC1=O)CC(C)c1ccc(S(=O)(=O)CC)cc1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.39
KMT2A Q03164 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 2/20 0.36
ADRA1B P35368 2/20 0.36
CYP2C19 P33261 1/20 0.36
KDM4E B2RXH2 1/20 0.36
RORC P51449 1/20 0.36
ADRA1A P35348 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GAA P10253 1/20 0.34
BCHE P06276 1/20 0.34
ACHE P22303 1/20 0.34
AOC2 O75106 2/20 0.34
RCE1 Q9Y256 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6979427 0.93 CYP2C19 (0.39) POLBKMT2ATDP1ALDH1A1ADRA1B
SCHEMBL6985013 0.92 KMT2A (0.39) POLBKMT2ATDP1ALDH1A1ADRA1B
SCHEMBL6977033 0.91 KMT2A (0.38) POLBKMT2ATDP1ALDH1A1ADRA1B
SCHEMBL6981559 0.90 ADRA1B (0.41) POLBKMT2ATDP1ADRA1BL3MBTL1
SCHEMBL6986602 0.88 KDM4E (0.41) POLBKMT2ATDP1ALDH1A1KDM4E
SCHEMBL6985684 0.88 ADRA1B (0.47) ADRA1BADRA1AL3MBTL1BCHEACHE
SCHEMBL6986401 0.86 TSHR (0.48) POLBKMT2AALDH1A1KDM4EL3MBTL1
SCHEMBL6985829 0.86 POLB (0.37) POLBKMT2ATDP1ALDH1A1ADRA1B
SCHEMBL6985492 0.85 POLB (0.38) POLBKMT2ATDP1ALDH1A1ADRA1B
SCHEMBL6987748 0.85 KCNH2 (0.41) ADRA1BADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289965-A1 SUBSTITUTED 1-AMINOALKYL-LACTAMS AND THEIR USE AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2003-03-12 EP disclosed
WO-2001090081-A1 SUBSTITUTED 1-AMINOALKYL-LACTAMS AND THEIR USE AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-11-29 WO disclosed